1. Home
  2. SY vs EOLS Comparison

SY vs EOLS Comparison

Compare SY & EOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SY
  • EOLS
  • Stock Information
  • Founded
  • SY 2013
  • EOLS 2012
  • Country
  • SY China
  • EOLS United States
  • Employees
  • SY N/A
  • EOLS N/A
  • Industry
  • SY EDP Services
  • EOLS Biotechnology: Pharmaceutical Preparations
  • Sector
  • SY Technology
  • EOLS Health Care
  • Exchange
  • SY Nasdaq
  • EOLS Nasdaq
  • Market Cap
  • SY 482.1M
  • EOLS 493.5M
  • IPO Year
  • SY 2019
  • EOLS 2018
  • Fundamental
  • Price
  • SY $3.81
  • EOLS $6.42
  • Analyst Decision
  • SY Strong Buy
  • EOLS Strong Buy
  • Analyst Count
  • SY 1
  • EOLS 5
  • Target Price
  • SY $5.50
  • EOLS $21.25
  • AVG Volume (30 Days)
  • SY 1.2M
  • EOLS 887.6K
  • Earning Date
  • SY 08-15-2025
  • EOLS 11-05-2025
  • Dividend Yield
  • SY 0.70%
  • EOLS N/A
  • EPS Growth
  • SY N/A
  • EOLS N/A
  • EPS
  • SY N/A
  • EOLS N/A
  • Revenue
  • SY $197,807,588.00
  • EOLS $277,941,000.00
  • Revenue This Year
  • SY $8.61
  • EOLS $13.68
  • Revenue Next Year
  • SY $54.55
  • EOLS $27.96
  • P/E Ratio
  • SY N/A
  • EOLS N/A
  • Revenue Growth
  • SY N/A
  • EOLS 17.15
  • 52 Week Low
  • SY $0.66
  • EOLS $5.71
  • 52 Week High
  • SY $6.28
  • EOLS $17.82
  • Technical
  • Relative Strength Index (RSI)
  • SY 46.57
  • EOLS 32.00
  • Support Level
  • SY $3.63
  • EOLS $7.19
  • Resistance Level
  • SY $4.15
  • EOLS $6.77
  • Average True Range (ATR)
  • SY 0.27
  • EOLS 0.30
  • MACD
  • SY 0.01
  • EOLS -0.07
  • Stochastic Oscillator
  • SY 56.05
  • EOLS 1.85

About SY So-Young International Inc. American Depository Shares

So-Young International Inc is an online destination for discovering, evaluating, and reserving medical aesthetic services in China. Its business model comprises four integrated components: professional content and its distribution through social media networks and its targeted media platforms in China, a social community characterized by signature user-generated content, Online reservation services for a medical aesthetic treatment, and the research, development, production, sales and agency of laser and other optoelectronic medical beauty equipment. It generates revenue from information services fees and reservation services fees from medical aesthetic service providers.

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company with a customer-centric approach to delivering breakthrough products in the self-pay aesthetic market. The company's first commercial product is Jeuveau, a proprietary 900 kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Its primary market is the cash-pay aesthetic market, which includes medical products purchased by physicians and other customers that are then sold to consumers or used in procedures for aesthetic indications. It generates product revenue from the sale of Jeuveau in the United States and Europe, and service revenue from distribution partners in Canada.

Share on Social Networks: